Bronchopulmonary dysplasia severity and bone status in preterm infants

Affiliations

¹ Division of Neonatology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA.
² Division of Nephrology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA.
³ Intermountain Health, Women and Newborn Clinical Program, Murray, Utah, USA.

Ariel Tarrell et al. Pediatr Pulmonol. 2024 Jun.

. 2024 Jun;59(6):1826-1828.

doi: 10.1002/ppul.26967. Epub 2024 Mar 19.

¹ Division of Neonatology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA.
² Division of Nephrology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah, USA.
³ Intermountain Health, Women and Newborn Clinical Program, Murray, Utah, USA.

No abstract available

Keywords: bronchopulmonary dysplasia; metabolic bone disease; prematurity.

References

1. Gaio P, Verlato G, Daverio M, et al. Incidence of metabolic bone disease in preterm infants of birth weight <1250 g and in those suffering from bronchopulmonary dysplasia. Clin Nutr ESPEN. 2018;23:234‐239.
1. Jensen E, White A, Liu P, et al. Determinants of severe metabolic bone disease in very low‐birth‐weight infants with severe bronchopulmonary dysplasia admitted to a tertiary referral center. Am J Perinatol. 2016;33(1):107‐113.
1. Montaner Ramón A. Risk factors of bone mineral metabolic disorders. Semin Fetal Neonat Med. 2020;25(1):101068.
1. Tong L, Gopal‐Kothandapani JS, Offiah AC. Feasibility of quantitative ultrasonography for the detection of metabolic bone disease in preterm infants ‐ systematic review. Pediatr Radiol. 2018;48(11):1537‐1549.
1. Malone Jenkins S, Chan G, Weaver‐Lewis K, Bardsley T, Felix J, Grinsell M. Vitamin D, bone density, and nephrocalcinosis in preterm infants: A prospective study. Pediatr Nephrol. 2022;37(6):1325‐1332.